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We discuss the use of time resolved fluorescence spectroscopy to extract fundamental
kinetic information on molecular species in tissues. The temporal profiles reveal the
lifetime and amplitudes associated with key active molecules distinguishing the local
spectral environment of tissues. The femtosecond laser pulses at 310 nm excite
the tissue. The emission profile at 340 nm from tryptophan is non-exponential due
to the micro-environment. The slow and fast amplitudes and lifetimes of emission
profiles reveal that cancer and normal states can be distinguished. Time resolved
optical methods offer a new cancer diagnostic modality for the medical community.
Copyright 2012 Author(s). This article is distributed under a Creative Commons
Attribution 3.0 Unported License. [http://dx.doi.org/10.1063/1.3697961]
I. INTRODUCTION
Optical spectroscopy is a novel approach for cancer detection and diagnosis in UV, visible and
NIR parts of the spectrum. It has two main advantages over the conventional methods: 1) no tissue
removal, and 2) in situ diagnosis in near real time. “Optical Biopsy” (OB), which encompasses optical
physics and medicine has been known since it’s first use in 1984 by Alfano.1 The native fluorescence
from malignant and nonmalignant breast and lung tissues were measured for the first time using
spectra analysis.1 OB is the only optical technique enabling the medical community to diagnose
disease without removing tissue sample. It is suitable for margins assessment when extracting
cancers in situ during surgery. Tissues contain a number of key fingerprint native endogenous
fluorophore molecules: tryptophan, collagen, elastin, reduced nicotinamide adenine dinucleotide
(NADH), flavin adenine dinucleotide (FAD) and porohyrins.2–4 The absorption and emission spectra
from key molecules in tissue are shown in Fig. 1.
“Optical biopsy” holds promise as clinical tool for diagnosing early stage of carcinomas and
other diseases by combining with available photonic technology in particular endoscope and ultrafast
streak camera technologies.
Fluorescence spectroscopy was used as a novel tool for detection of cancer in different tissue
types in late 1980s on breast, lung, liver and GYN tissues.1–3 The work was extended to differen-
tiate human malignant breast tissues from benign and normal tissue-types using UV excitation.2
OB technique can be used to extract intrinsic tissue fluorescence spectra during the induction of
morphological and molecular changes in human tissue in vivo. Typical fluorescence spectra from
ex vivo cancerous and normal breast tissue excited by 300 nm are shown in Fig. 2. Several groups
have investigated various promising approaches using optical fluorescence with high sensitivity and
specificity1–12 and Stokes Shift spectroscopy13–15 on different tissue types.
Time-resolved scattering and fluorescence spectroscopic measurements offer two optical physics
approaches to extract the key fingerprint relaxation parameters and information of the fluorophores
and scatterers in the medium and microenvironments of medium.16, 17 Theory of time-resolved
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FIG. 1. (a) Absorption and (b) emission spectra of key fluorophores in human tissues: tryptophan, collagen, elastin, NADH
and flavin.
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FIG. 2. Average fluorescence spectra of of cancerous (solid) and normal (dash) breast tissues obtained with the selective
excitation wavelength of 300 nm.
fluorescence polarization kinetics of fluorohores in solution was highlighted by G. Weber18 in
nanosecond range and by G. R. Fleming in picosecond regime.19 Alfano et al. demonstrated that
fluorescence decay lifetimes from human breast cell lines20 and rat kidney tissues21 in the UV to
NIR region and differentiated cancerous tissues from normal tissues.22 The time-resolved fluores-
cence polarization dynamics was extended from solution to high scattering tissue medium and was
systematically studied to investigate tissue microenvironment based on fundamentals of fluorophore
rotational kinetics.23, 24
Time resolved fluorescence measurements are lacking in the literature to obtain the key re-
laxation parameters: the nonradiative and radiative rates and quantum yield from different tissue
types.
The objective of this paper is to summarize the basic fluorescence and demonstrate the usefulness
of the time-resolved fluorescence spectroscopy techniques in medicine to obtain salient relaxation
parameters of non radiative and radiative rates and distinguish the malignant and benign tumor tissues
from normal tissues in various organs based on the differences of relaxation times and amplitude of
optical signals at different emission and excitation wavelengths.
II. TIME-RESOLVED FLUORESCENCE PHYSICS MODEL
Time-resolved fluorescence studies can provide direct relaxation information on various under-
lying physical processes on a molecular and macromolecular scale. The basic theory16 is used here to
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FIG. 3. Photo-physics processes in a simplified energy level diagram of a polyatomic organic molecule.
show how to extract the radiative and nonradiative from fluorescence dynamics. Direct picosecond
time-resolved techniques under 100 fs laser excitation enable the study of dynamics of relaxation in
macromolecules, particularly biopolymers such as proteins and nucleic acids using streak camera.
Using time-resolved spectroscopic techniques, one may be able to isolate the participating fluo-
rophores using wavelength selection of pump and emission using the supercontinuum fs and ps
pulses.25 This temporal analysis makes it possible to detect small changes in the environment of
chromophores in the tissues. Besides studying molecular structure and underlying dynamics, the
key parameters of fluorescence decay are determined and this can provide one with a new potential
technique for medical diagnostic purposes.
In the biomedical area, Alfano and Yao26 revitalized the use of light in dentistry by measuring
the fluorescence lifetimes for decayed and non-decayed regions of calcified tissue. Extending this
work, Alfano and his group found differences in fluorescence spectra and lifetimes from normal and
malignant rat tissues1 and later in human breast and lungs. They reported differences in fluorescence
spectra and lifetimes from non-cancerous and cancerous tissues.3, 27
The next section III demonstrates the potential use of spectral and temporal parameters for
applications in cancer to unveil the underlying physics from the rate equation analysis given in
reference 16. Femtosecond pulses provide δ(t) excitation to extract the risetime for the emission
fluorescence. The photo-physics involved in the underlying dynamics first starts with an organic
molecule being excited to S*n by an ultrashort delta δ(t) laser pulse in fs to ps range. The molecule
relaxes from the excited state S*n, such as the vibrational excited state S*1 in figure 3, to the lowest
level of the singlet state S1 through vibrational relaxation at a rate of k0, which gives vibrational
thermalization time, τ 0 = k0-1. The fluorescence rate is a measure of radiative and non-radiative
processes. The constant kR is the radiative decay rate (probability of radiative transition per second).
Various other non-emission channels denoted as non-radiative decay processes are described by the
rate kNR. These non-radiative decay processes may occur due to collision by diffusion, quenching of
emission by another species, energy transfer with fast rotational motion of the molecule, or transfer
with diffusion while the molecule itself relaxes to the ground state. In general, if the molecular decay
rates of internal conversion, intersystem crossing, and quenching are denoted as kIC, kIS, and kq,
respectively, then the non-radiative rate is given by
kNR = kIC + kIS + kq. (1a)
The fluorescence decay rate is obtained from the radiative and non radiative rates given as:
kF = kR + kNR, (1b)
where the fluorescence lifetime τ F = (kF)-1.
011103-4 Robert R. Alfano AIP Advances 2, 011103 (2012)
The rate equation describing the dynamics of photo excited organic molecules in tissue with
100 fs δ(t) pulse excitation follows. The molecules excited into the first excited electronic –vibrational
state S*1 are:
dns∗1
dt
= −k0ns∗1 + n0δ(t). (2)
Solving:
ns∗1 = n0e−k0t , (3)
where n0 is excited molecule of singlet S*1 at t = 0 and k0 is vibrational relaxation rate. The rate of
change of a number of molecules in the emitting state S1 can be expressed as
dns1
dt
= k0ns∗1 − kF ns1 (4)
where ns1 and ns∗1 are the number of molecules at the S1 and S
*
1 (vibrational excited state of S1)
levels, respectively.
For a δ-pulse excitation, substituting for the number of molecules in the S*1 state as ns∗1 =
n0e
−k0t
, one obtains
dns1
dt
= k0n0e−k0t − kF ns1 (5)
where n0 is the number of molecules at S*1 at time t = 0. This equation can be further written as
d(ns1 ekF t )
dt
= k0n0e(kF −k0)t . (6)
Integrating equation (6), one gets the population at S1 at t:
ns1 (t) =
k0n0
k0 − kF (e
−kF t − e−k0t ) (7)
The rise time gives the vibrational relaxation from S*1 of ∼ k0-1 and the decay ∼kF gives the
relaxation from S1 to the ground state.
The fluorescence intensity at time t is proportional to ns1 and can be expressed as
I (t) = kRnS1 (t) = kR
k0n0
k0 − kF (e
−kF t − e−k0t ) (8)
The rise rate k0 and decay rate kF are obtained from measured I(t) vs time. The time to rise to
the peak tp gives a measure of rise and decay parameters. Taking the derivative dI/dt = 0, the rise
time is given as
tP = ln(k0/kF)/(k0 − kF). (9)
The size of fluorescence signal and the temporal profile give a measure of the quantum
yield, Q:
Q = kR/(kR + kNR) = kR/kF. (10)
The yield:
Q = τN R
τR + τN R . (11)
For example, as a standard the parameters for Erythrosin dye in water are Q = 0.02 and τ F
= 68 ps. From Q and I(t) the values of τNR, τ F, and τ 0 can be obtained to characterize materials.
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FIG. 4. Time-resolved fluorescence experimental set-up using a colliding pulse mode-locked dye laser-amplified-SHG laser
system.
III. TIME-RESOLVED FLUORESCENCE STUDIES ON HUMAN BREAST TISSUES AT TWO
DIFFERENT PUMP WAVELENGTHS OF 301 nm AND 353 nm
Steady-state ultraviolet (UV) fluorescence spectroscopy has been used to separate malignant
tumors from benign and normal breast, cervical, ovarian, and uterus tissues and tumors. The tissue
samples were excited at 300 nm using a lamp-based spectrometer and the emission was recorded
from 320 nm to 550 nm as shown in figure 2. The ratios of fluorescence intensities at 340 nm to
440 nm for cancerous breast tissues were found to be different from that of normal and benign
tissues.
In order to obtain further information on the chromophores responsible for the emission and
to have a better physics picture of the heterogeneous nature of tissue fluorescence in cancerous
and normal tissue, the kinetics of the physical processes occurring in tissues are studied using
time-resolved fluorescence.
The key fluorescence relaxation decay parameters were determined from the time-resolved
fluorescence spectroscopic data from photo-excited tissues. Non-malignant (normal, benign tissue,
and benign tumor) and malignant breast tissues were excited at 310 nm and 353 nm. The measured
fluorescence kinetics from malignant and non-malignant tissues exhibit different double exponential
decay profiles consisting of slow and fast components.
A. Instrumentation
As an example, the schematic diagram of the time-resolved fluorescence experimental set-up
is displayed in figure 4. Ultrafast 100 fs laser pulses (repetition rate, 82 MHz; λ = 620 ± 5 nm;
beam diameter, 3 mm) of 0.1 nJ per pulse were generated from a colliding pulse mode-locked dye
laser system. These laser pulses were amplified by a sulphur rhodamine gain medium pumped by
a copper vapour laser at 6.5 kHz. 100 fs laser pulses at 310 nm wavelength serve at δ(t) pulse
were obtained by focusing the 620 nm beam onto a KDP crystal to generate the second harmonic.
Breast tissue samples were put in quartz cells and excited at this wavelength. The pulse energy at
the sample site was 0.5 μJ and the results were an average of a few tens of thousand pulses. The
fluorescence was collected onto Hamamatsu synchroscan streak camera with a temporal resolution
of 10 ps. The sampling volume was a fraction of 1 mm2 in area and about a millimeter in depth.
The tissue fluorescence was collected at the emission bands of 340±5 nm and 440±5 nm using
narrowband filters to measure tryptophan, and collagen/elastin molecules in tissue. The resulting
temporal profiles were fitted to double exponential impulse responses using nonlinear least-squares
method. One can use Ti: sapphire laser and SHG to excite tissues at different wavelengths. The best
choice for exciting biological materials for ultrafast physics studies is the Supercontinuum25 from
fibers, sapphire plates and solutions with wavelengths spanning from 400 nm to 2400 nm.
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B. Materials and Methods
Time-resolved fluorescence measurements were performed on 18 samples from human breast of
different subjects - six malignant tumors (all infiltrating ductal carcinomas; tumor cell differentiation
was varied; nuclear grade was also varied), five benign tissues (fibrocystic mastopathy), five normal
tissues (fibroglandular tissue and one lipoma) and two benign tumours (one fibroadenoma and one
adenofibroma). Normal tissue refers to normal glandular tissue; benign tissue includes fibrosis–
fibrous tissue; benign tumor includes fibroadenoma, which are neoplasms that usually do not recur
after excision.
Most of samples were obtained from biopsies and were fresh, almost blood free, and not
homogenized. They were obtained in chunks of about 5 mm × 5 mm × 5 mm in dimensions. The
pathologist made the diagnosis of the tissue type.
C. Results
Typical time-resolved fluorescence profiles at 340 nm emission band from a benign breast tissue,
a benign tumor and a malignant tumor, photoexcited at 100 fs 310 nm pulse, are displayed in Fig. 5.
The temporal curves contain one slow and one fast component of fluorescence decay. The profiles
for non-malignant (benign and normal) and malignant samples show a marked difference. The fast
component seems to be more dominant in non-malignant tissues than in malignant tissues.
The fluorescence decay curves for 440 nm band appear to contain one slow and one fast
component of fluorescence lifetime. Unlike the 340 nm band, there is no marked dominance of
either component for 440 nm.
The time-resolved fluorescence profile is fitted to data by the expression
I (t) = ase−
t
τs + a f e−
t
τ f (12)
The relaxation times and amplitudes of the fluorescence decay were obtained by a nonlinear
least-squares fitting of the curves to the above expression. These measurements were performed at
different points of the sample. It can be extended to a map of τ F(r) over the tissue surface. The double
exponential fit showed a chi-squared value close to 1, so that three or four component decay fits were
not tested. Because of alignment problems only the amplitudes were compared. Two histograms of
the amplitude ratios af/as and the slower decay time τ s are given in figures 6 and 7, respectively.
These histograms show the results for the 340 nm band which clearly distinguishes malignant from
non-malignant tissue types. The data can be used to create a contour map of τ F(r) on the surface of
a tissue for separating diseased parts from normal region. Figures 6 and 7 plots are showing results
separating cancerous and normal tissues using the time-resolved technique.
At the 340 nm band significant difference was found in the slow decay lifetimes of the malignant
samples were found to be about twice as large as those in the case of non-malignant samples.
The average τ s for non-malignant and malignant tissues were 1.16 ± 0.28 and 1.91 ± 0.16 ns,
respectively. The slower component was more dominant in malignant samples while the reverse was
true in the case of non-malignant samples. The average ratios of amplitudes af/as for non-malignant
and malignant tissues were 1.29 ± 0.51 and 0.39 ± 0.17, respectively. As the two histograms
show, the relative amplitudes and the slower component of the fluorescence relaxation time can
separate malignant breast tissues from non-malignant ones. There was consistency in the results
from various positions of the non-malignant samples. However, the malignant samples did show
variations towards non-malignant results at the peripheries when the sample was large. This was
consistent with the pathologist’s report of where the malignancy was located.
D. Discussion
From the results of the 340 nm band, a statistical study of these small number of samples was
performed using a student ‘t’ test. A ‘p’ value of less than 0.001 was obtained between non-malignant
and malignant results for τ s and af/as. The ‘p’ values were obtained separately for τ s and af/as. These
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FIG. 5. Time-resolved fluorescence profiles with 310 nm excitation and 340 nm emission. (a) malignant tumor: τ f = 79 ps
τ s = 1.99 ns, and Af/As = 0.5; (b) normal breast tissue: τ f = 46 ps τ s = 1.14 ns, and Af/As = 1.2; and (c) benign tumor: τ f
= 59 ps τ s = 0.89 ns, and Af/As = 2.58. All parameter were obtained by averaging.
results show how time-resolved fluorescence measurements can distinguish malignant tumors from
non-malignant tissues.
At the 440 nm emission band no significant and consistent differences in lifetimes or amplitudes
between malignant and non-malignant breast tissues were found arising from NADH, elastin and
collagen.
The fluorescence yield at the 340 nm band, excited by 310 nm has been suggested to arise
from tryptophan, or a combination of its residues. For λex greater than 295 nm, fluorescence from
tryptophan is more dominant than from tyrosine, both of which are present in most proteins.
Tryptophan and its residues in different microenvironments have long been known to show double
exponential fluorescence kinetics. The observation of double exponential fluorescence decays in
tissues at 340 nm band with a fast component in the subnanosecond range and a slow component
of about 1–2 ns suggests that the fluorescence could be from excited indole rings in tryptophan
residues.
For 351 nm excitation, no remarkable results are observed from 450 nm emission, which is
consistent with emission at 440 nm with 310 nm excitation.
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FIG. 6. The scatter plot of the amplitude ratios of Af/As (initial intensity of fast component to slow component) for normal
(square) breast tissue, benign (circle) and malignant (triangle) tumor.
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FIG. 7. The scatter plot of decay time (in nanosecond scale) vs. fast decay time (in picoseconds scale) of normal (square)
breast tissue, benign (circle) and malignant (triangle) tumor.
The difference in fluorescence lifetimes and the dominance of one decay amplitude to the other
in malignant and non-malignant tissues can be explained in two ways. One possibility could be
the presence of two tryptophan residues in different proportions in cancerous and non-cancerous
tissues. A second possibility could be due to different environments in the normal and abnormal
tissues. Amplitudes and decay times of individual tryptophan conformers are strongly influenced
by their microenvironments, such as different pH values and proximity of charged groups to the
chromophores. Different pH values sometimes lead to charge transfers that give rise to an enhanced
intramolecular interaction. This results in larger non-radiative energy losses. The dominance of the
fast amplitude in the case of non-malignant samples could be due to more non-radiative processes
occurring in the tryptophan residues of such tissues. The larger values of τ s for malignant tissues
suggest that more non-radiative processes occur in non-malignant tissue environments.
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IV. SUMMARY
Time-resolved fluorescence spectroscopy method is reviewed using cancerous ex vivo tissue
examples. The underlying physical and biological basis for cancer detection using optical approach
was revealed using human breast, prostate, colon, gastrointestinal and gynecological samples. The
results demonstrated that the emerging ultrafast time-resolved technique for optical biopsy in de-
tection of cancer is promising for future clinical screening diagnosis and other important medical
applications. An optical streak camera oscilloscope from Hamamatsu Corp. with optical fibers for
excitation and detection would be ideal to scan and map a tissue in vivo, 80 ps time gated imager,
such as a Picostar unit from LaVision can be used to obtain a 2D map of tissue.28, 29
In conclusion, the outcome of this paper shows that the time resolved fluorescence is a novel
way to obtain fundamental information on cancer.
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